Batuhan Orbay Yenilmez, PhD

Biography

Batuhan Yenilmez is an Assistant Professor at the University of Massachusetts Chan Medical School, where he leads a research program focused on developing next-generation RNA interference (RNAi)-based therapeutics in collaboration with world-renowned RNA chemists under the UMass Chan umbrella. His lab investigates metabolic and fibrotic diseases, with a particular emphasis on obesity, type 2 diabetes, metabolic dysfunction-associated steatohepatitis (MASH), and pulmonary fibrosis. By engineering tissue-selective RNAi molecules and exploring anti-fibrotic microRNAs, Dr. Yenilmez's work aims to uncover new therapeutic strategies for cardiometabolic and fibrotic disorders.